(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202312 | 202212 | % Var | 202312 | 202212 | % Var | 202303 | 202203 | % Var | |
| Sales | 3.28 | 4.27 | -23.19 | 4.80 | 7.03 | -31.72 | 10.19 | 3.65 | 179.18 |
| Other Income | 5.25 | 4.45 | 17.98 | 15.09 | 13.18 | 14.49 | 17.51 | 19.19 | -8.75 |
| PBIDT | 3.19 | 2.73 | 16.85 | 8.14 | 7.89 | 3.17 | 10.60 | 10.25 | 3.41 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 3.19 | 2.73 | 16.85 | 8.14 | 7.89 | 3.17 | 10.60 | 10.25 | 3.41 |
| Depreciation | 0.24 | 0.24 | 0.00 | 0.72 | 0.70 | 2.86 | 0.94 | 0.92 | 2.17 |
| PBT | 2.95 | 2.49 | 18.47 | 7.42 | 7.19 | 3.20 | 9.66 | 9.33 | 3.54 |
| TAX | 1.66 | 2.72 | -38.97 | 3.62 | 4.12 | -12.14 | 4.63 | 4.57 | 1.31 |
| Deferred Tax | 0.76 | 1.72 | -55.81 | 1.46 | 2.12 | -31.13 | 2.12 | 0.22 | 863.64 |
| PAT | 1.29 | -0.23 | -660.87 | 3.80 | 3.07 | 23.78 | 5.03 | 4.76 | 5.67 |
| Equity | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 |
| PBIDTM(%) | 97.26 | 63.93 | 52.12 | 169.58 | 112.23 | 51.10 | 104.02 | 280.82 | -62.96 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: